top of page

New Member: Welcome in our cluster to Tcelltech

Tcelltech was founded as a spin-off from DKFZ Heidelberg in 2022 and is developing personalized adoptive cell therapies. Its personalized T cell therapy has large therapeutic potential against multiple cancers and is based on two underlying technology platforms: an AI-based bioinformatics platform that allows for rapid tumor reactive T cell receptor identification and nanoSMAR a novel DNA based non-viral gene delivery system for transfecting T cells. Tcelltech is commercializing its gene delivery platform separately in non-core applications.

We are looking forward to see your active participation in the network!

You can find here more information about Tcelltech.


bottom of page